beta

CAPR

Capricor Therapeutics, Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA.

Market Cap: 77.3 Million

Primary Exchange: NASDAQ

Website: http://www.capricor.com

Shares Outstanding: 16.7 Million

Float: 16.3 Million

Dividend: (%)

Beta: 1.63123469927615

Sector: Health Technology

Industry: Biotechnology

Ethical Flags

Longest drawdown: 2175 trading days

From: 2014-01-23 To: 2020-05-29

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud